当前地点:

EN

选择地点:

Our History

  • 2025/10/17

    2025

    Adsorbed tetanus vaccine was marketedThe hepatitis A & hepatitis B combined vaccine, Bilive, has been re-registered and approved in China.SINOVAC LIFE CITY was opened

  • 2025/10/17

    2024

    Sabin Strains (Five-Dose) (2.5ml/vial) (hereinafter referred to as "msIPV") was prequalified by WHO

  • 2025/10/17

    2023

    SINOVAC joint venture KeyVac in Türkiye was started production

  • 2025/10/17

    2022

    SINOVAC's Sabin-strain inactivated polio vaccine (sIPV) and varicella vaccine were prequalified by the WHO.

  • 2025/10/17

    2021

    Sabin株脊髓灰质炎灭活疫苗(Vero细胞)上市2021.6.1新型冠状病毒灭活疫苗克尔来福列®入WHO紧急使用清单新型冠状病毒灭活疫苗克尔来福®在中国、智利、土耳其、巴西、印尼等数十个国家获批附条件上市或紧急使用

  • 2025/10/17

    2020

    水痘减毒活疫苗上市四价流感病毒裂解疫苗上市23价肺炎球菌多糖疫苗上市启动名为“克冠行动”的新型冠状病毒疫苗的研制工作,克尔来福®率先获批紧急使用公司第四个产业基地——北京大兴基地投入使用科兴控股(新加坡)有限公司注册成立

  • 2025/10/17

    2017

    甲肝灭活疫苗孩尔来福®通过世界卫生组织(WHO)预认证,成为我国唯一通过WHO预认证的甲肝疫苗

  • 2025/10/17

    2016

    全球首创的预防用生物制品1类新药——肠道病毒71型灭活疫苗益尔来福®上市

Previous page123Next page Go to No.